生存素
赫拉
紫杉醇
细胞凋亡
MTT法
化学
转染
癌症研究
流式细胞术
细胞周期
免疫印迹
癌细胞
细胞生长
分子生物学
细胞
癌症
生物
生物化学
基因
遗传学
作者
Fei Gu,Li L,Yuan Qf,Li C,LI Zh
出处
期刊:PubMed
日期:2017-08-01
卷期号:21 (15): 3504-3509
被引量:17
摘要
Paclitaxel is one of the common anticancer drugs in the treatment of cervical cancer, while the mechanism of restraining and killing cancer cells is still unclear. This study aimed to investigate the molecular mechanism of paclitaxel in regulating proliferation and apoptosis of cervical cancer Hela cells.Paclitaxel at 2 μmol/L was used to treat Hela cells for 48 h. MTT assay and flow cytometry were applied to test Hela cells proliferation and apoptosis respectively. Western blot was adopted to determine the expression of survivin. SiRNA was performed to suppress survivin protein expression in Hela cells.Paclitaxel restrained Hela cells growth and induced apoptosis. Also, paclitaxel treatment significantly reduced survivin protein expression in Hela cells. Moreover, survivin siRNA transfection further promoted Hela cells apoptosis after intervention by 2 μmol/L paclitaxel.Down-regulation of survivin promoted paclitaxel-induced apoptosis of cervical cancer Hela cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI